Active, not recruitingNot applicableNCT07214363

The Safety and Efficacy of Irreversible Electroporation for the Treatment of Perivascular Liver Cancers

Studying Pediatric hepatocellular carcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Taiwan University Hospital
Intervention
Irreversible Electroporation Ablation Generator(device)
Enrollment
20 target
Eligibility
20 years · All sexes
Timeline
2023 – 2026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07214363 on ClinicalTrials.gov

Other trials for Pediatric hepatocellular carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Pediatric hepatocellular carcinoma →

← Back to all trials